TRACON Pharmaceuticals to Present at Upcoming Investment Conferences
May 31, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 31, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON Pharmaceuticals Reports Granting of Inducement Award
May 20, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 20, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON Pharmaceuticals Initiates Dosing in Phase 1b/2 Study of TRC105 in Patients with Hepatocellular Carcinoma
May 18, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 18, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON Pharmaceuticals to Present at the UBS Global Healthcare Conference
May 16, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 16, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON Pharmaceuticals Reports First Quarter 2016 Financial Results and Provides Corporate Update
May 11, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 11, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON Pharmaceuticals Announces Initiation of Dosing in a Phase 1/2 Neoadjuvant Study of TRC105 in Patients with Breast Cancer
May 09, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 09, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON to Report First Quarter 2016 Company Highlights and Financial Results on May 11, 2016
May 04, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON Announces EMA Orphan Drug Designation for TRC105 in Soft Tissue Sarcoma
May 04, 2016 08:00 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, May 04, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON Announces Clinical Data Presentations at Upcoming ASCO Annual Meeting
April 21, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, April 21, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...
TRACON Pharmaceuticals Announces TRC105 Clinical Data Presentation at Upcoming AACR Annual Meeting
April 11, 2016 16:05 ET
|
TRACON Pharmaceuticals, Inc.
SAN DIEGO, April 11, 2016 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted...